SemaThera's Series A Round

SemaThera raised a round of funding on March 21, 2018.

SemaThera is a biotechnology company focusing on the development of novel SEMA 3A TRAP inhibitors for the treatment of ocular diseases, such as diabetic macular edema.…

Articles about SemaThera's Series A Round: